Literature DB >> 10439526

Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil.

T Darben1, J Savige, R Prentice, B Paspaliaris, J Chick.   

Abstract

The association of pyoderma gangrenosum and arthritic symptoms is well documented. We present a rarely reported variant of this in a 44-year-old woman with pyoderma gangrenosum and bilateral large purulent effusions of her knees. She had no evidence of underlying rheumatoid arthritis or a specific seronegative spondyloarthropathy. Of note she had a history of Graves' disease for which she had been treated with propylthiouracil for 3 years and on investigation at this presentation had a markedly elevated perinuclear antineutrophil cytoplasm antibody (P-ANCA) level with specificities for IgM myeloperoxidase, IgG elastase and IgG lactoferrin. We believe this patient had pyoderma gangrenosum with secondary sterile pyarthrosis and a P-ANCA precipitated by propylthiouracil.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439526     DOI: 10.1046/j.1440-0960.1999.00346.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

Review 1.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Min Chen; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

2.  ANCA positive propylthiouracil induced pyoderma gangrenosum.

Authors:  K Gungor; S Gonen; G Kisakol; O Dikbas; A Kaya
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

3.  A Case of p-ANCA-Positive Propylthiouracil-Induced Pyoderma Gangrenosum.

Authors:  Jong Won Seo; Hyun Ho Son; Joon Hee Choi; Sook Kyung Lee
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.